AmfAR is one of the world’s biggest non-profit organizations and deals with AIDS prevention, AIDS research and the training of medical personnel in the fight against HIV and AIDS as well as how to directly help HIV infected patients. AmfAR also advocates the implementation of reasonable AIDS policy. Since its inception in 1985, amfAR has invested more than $450 million in its programs to end the global AIDS epidemic through innovative research – and has awarded grants to more than 3,300 research teams worldwide.
amfAR & LIFE+
The partnership between LIFE+ and amfAR began in 2005, when the organization, founded by Liz Tayler and Dr. Mathilde Krim, and its project TREAT Asia was the first recipient of the “Life Ball Crystal of Hope Award”. TREAT Asia is a network of medical facilities in Southeast Asia that ensures the medical treatment of patients infected with HIV or suffering from AIDS. Due to the lack of qualified doctors in this area, one of the main goals is the medical and social training of specialized staff and those affected by HIV and AIDS. The collaboration with amfAR marked an important step in the development of LIFE+ and its fight against HIV and AIDS, since the direct help could be extended to important research.
With the support of LIFE+ in 2006, amfAR developed an expansion of the TREAT Asia project with the TREAT Asia Pediatric HIV/AIDS Network. Ever since, LIFE+ has supported this project with roughly EUR 500,000 eachyear.
The most important concerns in building the network “children with HIV/AIDS” are:
The establishment of secure standards for the treatment of kids
The exchange of know-how between clinics and research institutes
The education of doctors for the treatment of infants and children
The collection and analysis of patient data in order to standardize therapies and dosage of medication for children
TREAT Asia is a network of clinics, hospitals, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatment throughout Asia and the Pacific. Facilitated by amfAR, TREAT Asia seeks to strengthen HIV/AIDS care, treatment, and management skills among health care professionals through education and training programs developed by experts in the region.
Complex treatment of HIV-positive children
The challenges in the HIV treatment of children are particularly complex: they need a different dosage, must cope with the various side effects of the medication, and are not immune to discrimination and social exclusion. This is why in 2005 amfAR developed an extension of the TREAT Asia project: the TREAT Asia Pediatric HIV/AIDS Network. It was created in order to establish a regional association of pediatric HIV clinicians, researchers, and orphan advocates and to establish a pediatric HIV observational database for epidemiologic research. As of 2016, over 5,000 children are already saved in through this database
Research for the benefit of HIV-positive children worldwide
Consisting of 22 clinics or programs that operate on the front lines of pediatric AIDS treatment and research in Asia, the TREAT Asia pediatric network involves sites in Cambodia, China, India, Indonesia, Laos, Malaysia, Thailand, and Vietnam. Since it was formally launched in November 2006, the TREAT Asia Pediatric HIV/AIDS Initiative has developed into one of the most dynamic and effective regional resources to evaluate and address the treatment needs of children living with HIV.
The impact and benefits of TREAT Asia’s pediatric program is also generating knowledge that is helpful for advancing treatment for HIV-positive children across the world. With a financial support of half a million Euros per year since 2006, LIFE+ is one of the program’s biggest donor.